Sanofi Pasteur is seeking partners who will share the company's pursuit of innovation and drive for excellence, while becoming a part of our market success story. Our diverse culture and geography allow us to collaborate effectively with a broad array of partners around the world.
We are not only at the forefront of conquering newly targeted infectious diseases, but also leading the way in expanding immunization across all age groups, including adolescents and the elderly.
We welcome the opportunity to evaluate technologies related to the development and production of human vaccines, both prophylactic and therapeutic, including vaccines for chronic infectious diseases.
Sanofi Pasteur has a strong commitment to Research and Development partnerships with major universities, research institutes, government bodies, biotechnology companies and contract research organizations. The company's collaborations cover virtually all aspects of vaccine development, including early-stage research.
Examples of current partnerships and technology investments include: vaccines for dengue fever, Japanese encephalitis, S. pneumoniae, and M. tuberculosis; pediatric combination vaccines; herpes simplex virus; large-scale, cell culture-based virus production; adjuvants and immunomodulators; conjugate vaccine production; and vaccine delivery systems.
A company partnering with Sanofi Pasteur interacts with a multidisciplinary team that has years of experience in working to ensure that partnerships are executed succesfully and nurtured for the mutual benefit of all parties.
This approach utilizes the value-added Sanofi Pasteur alliance management capability, which focuses on the relationship by facilitating open communication, trust, understanding and clear expectations across the project lifespan. Combined with the technical competency of the alliance, this balance provides a well rounded environment for your technology to flourish.